Multiple Sclerosis News Today | Symptoms, Diagnosis, Treatments
Get the latest multiple sclerosis news, patient views, and caregiver perspectives from one of the largest MS communities online.
ECTRIMS 2024: Tolebrutinib may target smoldering inflammation
Sep 23, 2024 · The findings were presented in a pair of Sanofi-sponsored late-breaking presentations at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) annual meeting, which was ...
Top 10 MS news stories of 2024
Dec 31, 2024 · The team at Multiple Sclerosis News Today has brought our audience the latest news about treatments, scientific research, and clinical trials in multiple sclerosis (MS) throughout 2024. Here is a ...
1-year fenebrutinib inhibits nearly all MS signs in relapsing MS trial
Sep 6, 2024 · News; 1-year fenebrutinib curbs nearly all disease activity in relapsing MS trial ... to present the data in more detail at the upcoming Congress of the European Committee for Treatment and ...
Top 10 MS stories of 2023 - Multiple Sclerosis News Today
Jan 2, 2024 · Throughout 2023, Multiple Sclerosis News Today brought consistent coverage to our readers of the latest scientific research, developments in treatment, and clinical trials for multiple sclerosis (MS).
ACTRIMS 2024 - Multiple Sclerosis News Today
Multiple Sclerosis News Today is providing coverage of the ninth annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2024 Feb. 29-March 2 in West Palm Beach ...
ACTRIMS 2024: 2 treatments to aid remyelination in MS nearing...
Mar 6, 2024 · Lang discussed the development of the new treatment candidates at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2024, which was held last week virtually ...
FDA grants tolebrutinib breakthrough therapy designation in SPMS
Dec 17, 2024 · In addition to HERCULES, Sanofi’s clinical development program for tolebrutinib included three other Phase 3 trials: the identical GEMINI 1 (NCT04410978) and GEMINI 2 (NCT04410991) studies ...
AAN 2024: In MS study, long-term CNM-Au8 shows myelin, nerve …
Apr 18, 2024 · Note: The Multiple Sclerosis News Today team is providing coverage of the American Academy of Neurology (AAN) 2024 Annual Meeting April 13-18. Go here to see the latest stories from the conference.
Study: MS fatigue can be eased with both modafinil and talk therapy
Oct 21, 2024 · Medicine, talk therapy for fatigue. To find out, the University of Michigan sponsored a clinical trial called COMBO-MS (NCT03621761) that enrolled 336 adults with MS-related fatigue that had been ...